Europe Syndromic Multiplex Diagnostic Market
市场规模（十亿美元）
CAGR :
% 
USD
1.17 Billion
USD
2.19 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 1.17 Billion |
 Market Size (Forecast Year) |
USD 2.19 Billion |
 CAGR |
% |
| Major Markets Players |
|
歐洲綜合多重診斷市場細分，依產品類型（配件及耗材、儀器、軟體及服務）、感染類型（病毒、細菌、真菌、寄生蟲等）、疾病（呼吸道感染、胃腸炎、性傳播感染、腦膜炎、兒童感染、免疫抑制、熱帶熱、肝炎、眼部感染等疾病）、最終用戶（醫院、臨床實驗室、醫生辦公室、製藥及製藥公司（30 年）
綜合多重診斷市場分析
由於對快速、準確診斷的需求不斷增長以及傳染病的增多，綜合徵多重診斷市場正在經歷顯著增長。這些診斷平台可以同時檢測多種病原體，從而提高效率並改善患者預後。關鍵驅動因素包括分子診斷技術的進步、政府對醫療基礎設施的投資以及個人化醫療意識的不斷增強。此外，新冠疫情加速了多重診斷系統的普及。領先的市場參與者正專注於產品創新並擴大其區域影響力，從而進一步增強市場競爭力，並促進歐洲醫療保健產業的整體成長。
綜合多重診斷市場規模
歐洲綜合多重診斷市場預計將從 2024 年的 11.7 億美元增至 2032 年的 21.9 億美元，在 2025 年至 2032 年的預測期內以 8.2% 的複合年增長率增長。除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情境、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。
症候群多重診斷市場趨勢
“綜合多重診斷中即時檢驗的興起”
即時檢測是歐洲綜合多重診斷市場的重要趨勢。快速現場診斷的需求日益增長，推動了便攜式、易用的多重檢測設備的普及。這些即時檢測解決方案能夠更快地檢測多種病原體，從而透過及時的治療決策改善患者預後。這一趨勢在緊急情況下、農村地區以及疫情爆發期間尤其重要，因為在這些情況下，快速診斷至關重要。隨著微型診斷技術的進步，這些設備正變得更加精準、經濟高效且用戶友好，顯著提升了其在歐洲醫療保健服務中的作用。
報告範圍和綜合多重診斷市場細分
|
屬性 |
綜合徵多重診斷關鍵市場洞察 |
|
涵蓋的領域 |
|
|
覆蓋國家 |
德國、英國、法國、義大利、西班牙、俄羅斯、荷蘭、瑞士、土耳其、比利時、瑞典、波蘭、丹麥、挪威、芬蘭和歐洲其他地區 |
|
主要市場參與者 |
F. Hoffmann-La Roche Ltd（瑞士）、DiaSorin SpA（義大利）、BIOMÉRIEUX（法國）、Thermo Fisher Scientific Inc.（美國）、QIAGEN（荷蘭）、BD Veritor (BD)（美國）、Bio-Rad Laboratories, Inc.（美國）、Danaher Corporation（美國）、Sgenesch Corporation. GmbH（德國）、Abbott（美國）、QuidelOrtho Corporation（美國）、Biocartis（比利時）和 PathoFinder（荷蘭）等 |
|
市場機會 |
|
|
加值資料資訊集 |
除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括深入的專家分析、進出口分析、定價分析、生產消費分析和 PESTLE 分析。 |
症候群多重診斷市場定義
歐洲綜合多重診斷市場是指能夠同時檢測單一樣本中的多種病原體或生物標記的診斷測試和平台，以便能夠快速診斷各種疾病，包括傳染病、癌症和遺傳性疾病。這些診斷方法使醫療保健提供者能夠快速識別患者症狀的病因，從而改善治療效果並降低醫療成本。該市場的發展受到分子診斷技術進步、對更快、更準確的檢測需求不斷增長以及對個人化醫療日益增長的關注的推動。
症候群多重診斷市場動態
驅動程式
- 傳染病發生率上升
整個歐洲的傳染病負擔正在迅速加重。各種類型的病原微生物都與傳染病有關，例如病毒、真菌、細菌和寄生蟲。隨著傳染病的發生頻率和複雜性不斷增加，對更有效率、快速和全面的診斷工具的需求變得至關重要。綜合徵多重診斷技術提供了一種解決方案，可以在一次檢測中同時檢測多種病原體，這種能力在應對新發和復發的傳染病時正變得越來越重要。傳染病病例的增加提高了綜合徵多重診斷的診斷率，而傳染病的日益普及又推動了市場的成長。
例如，
2023年12月，世衛組織報告稱，季節性呼吸道感染在世衛組織歐洲區域激增，呼吸道合胞病毒、新冠肺炎、流感和肺炎支原體導致住院人數增加。幼兒、老年人和患有基礎疾病的人面臨更高的風險。加強預防措施，包括疫苗接種和衛生習慣，對於減輕疾病和醫療保健系統負擔仍然至關重要。
歐洲各地傳染病的盛行率不斷上升，推動了對先進診斷解決方案的需求。綜合多重診斷技術能夠在一次檢測中檢測多種病原體，滿足了人們對快速且準確疾病識別日益增長的需求。這一趨勢顯著推動了市場成長。
- 分子診斷技術的應用日益廣泛
分子診斷是一個快速發展和變革的領域，正在徹底改變疾病的檢測、治療和研究。它能夠精確識別傳染病，通常可在早期發現。在分子診斷中，多重PCR（聚合酶鍊式反應）面板檢測用於透過同時檢測各種病原體的遺傳物質來診斷傳染病。這些檢測可以跨多個分類學水平識別不同類型的微生物，包括真菌、寄生蟲、細菌和病毒。
隨著對分子診斷技術的日益依賴，病原體檢測變得更加全面和高效。多重PCR和先進的定序技術在快速且準確的疾病診斷中發揮著至關重要的作用，最終改善患者的預後。對精準及時的醫療保健解決方案的需求日益增長，推動著市場創新，從而增強臨床決策能力並制定更有效的治療策略。
例如，
2024年3月，愛思唯爾公司發表的一篇文章指出，分子診斷技術（尤其是基於PCR的方法）的日益普及，大大改變了傳染病的診斷方式。經FDA核准的多重PCR檢測組如今能夠高靈敏度、快速地檢測出導致呼吸道感染的病原體。這些檢測組不僅能夠及時且準確地進行診斷，還能幫助指導抗菌治療決策，最終改善臨床療效並優化患者照護。
分子診斷和綜合多重檢測技術的應用日益廣泛，它們能夠快速、精準地檢測各種感染，重塑醫療保健系統。這些創新簡化了診斷流程，降低了成本，並提高了治療的準確性，使其成為治療複雜疾病和改善全球患者護理的重要工具。
機會
- 人工智慧與自動化的進步
Advancements in AI and automation are transforming the Europe syndromic multiplex diagnostic market by enhancing processes’ accuracy, efficiency, and speed. AI-driven algorithms are being integrated into syndromic diagnostic platforms to analyze complex datasets, identify pathogens more precisely, and reduce the likelihood of false positives or negatives. Machine learning models are streamlining result interpretation, enabling faster clinical decision-making, and minimizing human errors. Automation further optimizes sample handling, processing, and result generation, reducing the dependency on skilled personnel and improving overall laboratory workflow efficiency. AI-powered predictive analytics are also aiding in early disease detection and outbreak monitoring, allowing healthcare providers to take proactive measures. Integrating automation with syndromic multiplex diagnostics ensures consistent and high-throughput testing. This is especially beneficial for large healthcare facilities and diagnostic centers handling high patient volumes. As AI continues to evolve, its role in refining syndromic diagnostic accuracy and reducing time is becoming increasingly critical.
For instance,
In December 2024, as per an article outlined by NCBI, the future advancements in syndromic multiplex diagnostics may involve integrating Rapid multiplex molecular syndromic panels (RMMSP) with predictive artificial intelligence, improving diagnostic accuracy and optimizing the management of critically ill, infected patients. AI-driven automation can enhance result interpretation, reduce human errors, and streamline workflows.AI automation and molecular innovations will redefine diagnostics, increasing efficiency and precision while improving patient care. This evolution will unlock new possibilities for syndromic multiplex diagnostics, driving advancements in disease detection and healthcare outcomes.
AI-driven algorithms improve pathogen detection, reduce errors, and accelerate clinical decisions. Automation streamlines sample processing and minimizes reliance on skilled staff. AI-powered analytics aid in early disease detection, boosting diagnostic capacity. These advancements present a significant opportunity by enhancing efficiency and accessibility, fostering market expansion.
- Rising Aging Population in Europe
As people age, their immune systems weaken, making them more susceptible to infections, increasing the demand for advanced diagnostic technologies. These solutions enable early detection, timely treatment, and improved healthcare outcomes, driving market expansion and innovation in diagnostic solutions.
For instance,
In February 2025, as per the information published by Eurostat an official website of European Union, as of January 1, 2024, the EU population was estimated at 449.3 million, with over 21.6% aged 65 and older, and a median age of 44.7 years. These growing elderly demographic increases demand for advanced diagnostics, acting as opportunity for the market growth.
With over 21% of Southern Europe’s population already aged 65+, and the EU’s elderly population projected to nearly double by 2060, the demand for advanced diagnostics is set to rise. As aging weakens the immune system, increasing susceptibility to infections, syndromic multiplex diagnostics will play a vital role in early detection and timely treatment, creating opportunity for market expansion.
Restraints/Challenges
- High Cost of Diagnostic Products
Smaller healthcare facilities and under-resourced settings struggle to adopt these advanced technologies due to financial constraints. The syndromic multiplex diagnostic also includes fully-automated, random access, multiplex testing for clinical diagnostic assays for rapid and accurate diagnostic test, however all this product are expensive to be purchased by the end users which is hampering the growth of the market.
The instruments which are used in the syndromic multiplex diagnostic are require high maintenance cost also it is very expensive in the nature same as with the reagents & consumables, for this reason high cost of diagnostic products is acting as a restraint for hampering the growth of Europe syndromic multiplex diagnostic market.
- Challenges in Detecting Resistance Mechanisms
While syndromic panels offer rapid and comprehensive pathogen identification, they often fail to detect specific antimicrobial resistance mechanisms, crucial for determining the most appropriate antibiotic therapy. This limitation increases the risk of inappropriate or ineffective treatments, potentially contributing to the growing problem of antimicrobial resistance. Infections caused by multidrug-resistant organisms require precise identification of resistance markers to ensure timely and targeted interventions, yet the inability of some syndromic tests to provide this information hinders clinical decision-making. Healthcare providers may still need to rely on additional conventional testing methods, increasing diagnostic time and costs, which reduces the overall efficiency of syndromic testing. As regulatory bodies and healthcare institutions emphasize the importance of antimicrobial stewardship programs, the need for enhanced syndromic diagnostic solutions that effectively detect resistance mechanisms becomes more pressing. The inability to fully address this issue limits the adoption of syndromic panels and slows the growth of the Europe syndromic multiplex diagnostic market.
For instance,
In February 2023, as per an article by NCBI, Genotypic tests struggled to detect non-enzymatic resistance mechanisms like porin loss or efflux pump upregulation and only predicted resistance, not susceptibility. Their high cost and limited clinical validation raise concerns about utility, especially for Gram-negative bacteria. These limitations pose a significant challenge for the market, restricting its effectiveness in guiding precise antimicrobial therapy.
本市場報告詳細介紹了最新發展動態、貿易法規、進出口分析、生產分析、價值鏈優化、市場份額、國內和本地市場參與者的影響，並分析了新興收入來源、市場法規變化、戰略市場增長分析、市場規模、品類市場增長、應用領域和主導地位、產品審批、產品發布、地域擴張以及市場技術創新等方面的機遇。如需了解更多市場信息，請聯繫 Data Bridge 市場研究部門獲取分析師簡報，我們的團隊將協助您做出明智的市場決策，實現市場成長。
症候群多重診斷市場範圍
根據產品類型、感染類型、疾病、最終用戶和分銷管道，市場細分為五個顯著的細分市場。這些細分市場的成長將有助於您分析行業中成長乏力的細分市場，並為用戶提供有價值的市場概覽和市場洞察，幫助他們做出策略決策，確定核心市場應用。
產品類型
- 配件和耗材
- 面板
- 多重呼吸面板
- 多重下呼吸道檢查
- 肺炎 (PN)/肺炎加重 (PNPLUS) 檢測組
- Unyvero LRT 測試
- 其他
- 多重上呼吸道檢查
- 呼吸道病毒檢測組
- 呼吸道病原體小組（RPP）/呼吸道小組 2（RP2）
- 呼吸系統檢查 EZ（Clia 豁免）
- 呼吸道病原體柔性測試（RP Flex）
- 其他面板
- 多重胃腸道檢測板
- 胃腸道病原體檢測組 (GPP)
- 腸道細菌組
- 腸病毒檢測組
- 腸道寄生蟲小組
- 擴展腸道細菌檢測組
- 其他面板
- 多重血培養板
- BCID 檢測小組（廣譜病原體鑑定）
- BCID-GP 檢測組（革蘭氏陽性菌檢測組）
- BCID-GN 檢測組（革蘭氏陰性細菌檢測組）
- BCID-FP 檢測組（真菌病原體檢測）
- 革蘭氏陽性菌血液培養檢測（BC-GP）
- 血液培養檢驗（BC-GN）
- 念珠菌小組
- 細菌面板
- 表型測試 BC
- 其他面板
- 多重下呼吸道檢查
- 腦膜炎/腦炎症候群小組
- STI 測試面板
- 其他綜合徵多重診斷面板
- 多重呼吸面板
- 其他的
- 面板
- 儀器
- 軟體與服務
感染類型
- 病毒性的
- 鼻病毒
- 新冠病毒
- 輪狀病毒
- 腺病毒
- 其他的
- 細菌
- 葡萄球菌
- 肺炎支原體
- 百日咳博德氏菌
- 其他的
- 真菌
- 寄生蟲
- 其他的
疾病
- 呼吸道感染
- 胃腸炎
- 性傳染感染
- 腦膜炎
- 兒童感染
- 免疫抑制
- 熱帶熱
- 肝炎
- 眼部感染
- 其他疾病
最終用戶
- 醫院
- 按類型
- 民眾
- 私人的
- 依等級
- 第 1 層
- 第 2 層
- 第 3 層
- 按類型
- 臨床實驗室
- 私人的
- 民眾
- 醫生辦公室
- 製藥和生物技術公司
- 研究機構
- 其他的
分銷管道
- 直接投標
- 零售銷售
- 在線的
- 離線
- 其他的
症候群多重診斷市場區域分析
對市場進行分析，並根據上述產品類型、感染類型、疾病、最終用戶和分銷管道提供市場規模洞察和趨勢。
由於對快速準確的診斷結果的需求不斷增加以及市場參與者採取的戰略舉措，德國預計將在市場上處於領先地位並快速增長。
報告的國家部分還提供了各個市場的影響因素以及國內市場監管變化，這些變化會影響市場的當前和未來趨勢。下游和上游價值鏈分析、技術趨勢、波特五力模型分析以及案例研究等數據點是預測各國市場情景的一些指標。此外，在對國家/地區數據進行預測分析時，還考慮了歐洲品牌的存在和可用性，以及由於來自本地和國內品牌的激烈或稀缺競爭而面臨的挑戰，國內關稅和貿易路線的影響。
症候群多重診斷市佔率
市場競爭格局按競爭對手提供詳細資料。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投入、新市場計劃、歐洲業務、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度以及應用主導地位。以上提供的數據點僅與公司在市場中的重點相關。
在市場上運作的綜合徵多重診斷市場領導者是：
- F. Hoffmann-La Roche Ltd（瑞士）
- DiaSorin SpA（義大利）
- 生物梅里埃（法國）
- 賽默飛世爾科技公司（美國）
- QIAGEN（荷蘭）
- BD Veritor (BD)（美國）
- Bio-Rad Laboratories, Inc.（美國）
- 丹納赫公司（美國）
- Seegene Inc.（韓國）
- Hologic公司（美國）
- 博世醫療解決方案有限公司（德國）
- 雅培（美國）
- QuidelOrtho Corporation（美國）
- Biocartis（比利時）
- PathoFinder（荷蘭）
綜合徵多重診斷市場的最新發展
- 2024年11月，羅氏達成協議，以約10億美元收購Poseida Therapeutics公司。此次收購增強了羅氏在同種異體細胞療法方面的能力，尤其是在腫瘤學、免疫學和神經病學領域。該收購旨在加速現成CAR-T療法的開發，透過增加治療可及性和改善臨床療效，使患者受益。預計交易將於2025年第一季完成。
- 2024年9月，羅氏推出了首款採用其突破性TAGS技術的檢測產品，可同時高通量檢測12種呼吸道病毒。全新TAGS（溫度活化訊號產生）技術可在高通量分子診斷分析儀cobas 5800、6800和8800上，在單一患者樣本中同時檢測多達15種目標病毒。
- 2023年3月，羅氏公司宣布，美國FDA腫瘤藥物諮詢委員會投票支持Polivy合併R-CHOP方案治療既往未治療的瀰漫大B細胞淋巴瘤(DLBCL)。與標準R-CHOP方案相比，此聯合方案顯著改善了患者的無惡化存活期，為DLBCL患者提供了相當前景的第一線治療方案。該決定預計將改善這種惡性腫瘤患者的預後，過去20年來，該類癌症的治療進展有限。
- 2022年3月，MDiaSorin旗下的Luminex xMAP NxTAG胃腸道病原體檢測試劑盒（GPP）獲得CE認證，試劑盒是多重檢測試劑，可檢測糞便樣本中的16種細菌、病毒和寄生蟲病原體。該試劑盒專為MAGPIX系統設計，可當天出結果，從而增強歐洲各地臨床實驗室的快速診斷、抗生素管理和高通量檢測能力。
- 2023年5月，DiaSorin SpA與MeMed簽署了MeMed BV檢測在義大利的經銷協議，進一步加強了雙方的合作關係。該檢測整合了人工智慧技術，可區分細菌感染和病毒感染，從而輔助抗生素決策。該檢測已在全球範圍內得到驗證，可增強患者管理，並支持對抗抗生素抗藥性的措施。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 INDUSTRY INSIGHTS
4.4 TECHNOLOGY ROADMAP
5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF INFECTIOUS DISEASES
6.1.2 RISING ADOPTION OF MOLECULAR DIAGNOSTICS TECHNIQUES
6.1.3 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS
6.1.4 INCREASING DEMAND FOR FAST AND ACCURATE DIAGNOSTIC RESULTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS
6.2.2 VARIABILITY IN TEST PERFORMANCE ACROSS DIFFERENT MANUFACTURERS
6.3 OPPORTUNITIES
6.3.1 ADVANCEMENTS IN AI & AUTOMATION
6.3.2 RISING AGING POPULATION IN EUROPE
6.3.3 RISING HOSPITAL-ACQUIRED INFECTIONS
6.4 CHALLENGES
6.4.1 CHALLENGES IN DETECTING RESISTANCE MECHANISMS
6.4.2 LACK OF MEDICAL PROFESSIONALS IN EUROPE
7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 ACCESSORIES & CONSUMABLES
7.2.1 PANELS
7.2.1.1 MULTIPLEX RESPIRATORY PANELS
7.2.1.1.1 MULTIPLEX LOWER RESPIRATORY PANELS
7.2.1.1.2 PNEUMONIA (PN)/PNEUMONIA PLUS (PNPLUS) PANELS
7.2.1.1.3 UNYVERO LRT TEST
7.2.1.1.4 OTHER
7.2.1.2 MULTIPLEX UPPER RESPIRATORY PANELS
7.2.1.2.1 RESPIRATORY VIRAL PANEL
7.2.1.2.2 RESPIRATORY PATHOGEN PANEL (RPP)/RESPIRATORY PANEL 2 (RP2)
7.2.1.2.3 RESPIRATORY PANEL EZ (CLIA-WAIVED)
7.2.1.2.4 RESPIRATORY PATHOGENS FLEX TEST (RP FLEX)
7.2.1.2.5 OTHER PANELS
7.2.1.3 MULTIPLEX GI PANELS
7.2.1.3.1 GI PATHOGEN PANEL (GPP)
7.2.1.3.2 ENTERIC BACTERIAL PANEL
7.2.1.3.3 ENTERIC VIRAL PANEL
7.2.1.3.4 ENTERIC PARASITE PANEL
7.2.1.3.5 EXTENDED ENTERIC BACTERIAL PANEL
7.2.1.3.6 OTHER PANELS
7.2.1.4 MULTIPLEX BLOOD CULTURE PANELS
7.2.1.4.1 BCID PANEL (BROAD-SPECTRUM PATHOGEN IDENTIFICATION)
7.2.1.4.2 BCID-GP PANEL (GRAM-POSITIVE BACTERIA PANEL)
7.2.1.4.3 BCID-GN PANEL (GRAM-NEGATIVE BACTERIA PANEL)
7.2.1.4.4 BCID-FP PANEL (FUNGAL PATHOGEN DETECTION)
7.2.1.4.5 GRAM-POSITIVE BLOOD CULTURE TEST (BC-GP)
7.2.1.4.6 BLOOD CULTURE TEST (BC-GN)
7.2.1.4.7 CANDIDA PANEL
7.2.1.4.8 BACTERIA PANEL
7.2.1.4.9 PHENOTEST BC
7.2.1.4.10 OTHER PANELS
7.2.1.5 MENINGITIS/ENCEPHALITIS SYNDROMIC PANEL
7.2.1.6 STI TEST PANELS
7.2.1.7 OTHER SYNDROMIC MULTIPLEX DIAGNOSTIC PANELS
7.3 INSTRUMENTS
7.4 SOFTWARE & SERVICES
8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE
8.1 OVERVIEW
8.2 VIRAL
8.2.1 RHINOVIRUS
8.2.2 CORONAVIRUS
8.2.3 ROTAVIRUS
8.2.4 ADENOVIRUS
8.2.5 OTHERS
8.3 BACTERIAL
8.3.1 STAPHYLOCOCCUS
8.3.2 PNEUMONIA
8.3.3 BORDETELLA PERTUSSIS
8.3.4 OTHERS
8.4 FUNGAL
8.5 PARASITES
8.6 OTHERS
9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE
9.1 OVERVIEW
9.2 RESPIRATORY INFECTIONS
9.3 GASTROENTERITIS
9.4 SEXUALLY TRANSMITTED INFECTIONS
9.5 MENINGITIS
9.6 CHILDHOOD INFECTIONS
9.7 IMMUNOSUPPRESSION
9.8 TROPICAL FEVER
9.9 HEPATITIS
9.1 EYE INFECTIONS
9.11 OTHER DISEASES
10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 BY TYPE,
10.2.1.1 PRIVATE
10.2.1.2 PUBLIC
10.2.2 BY LEVEL
10.2.2.1 TIER 1
10.2.2.2 TIER 2
10.2.2.3 TIER 3
10.3 CLINICAL LABORATORIES
10.3.1 BY TYPE
10.3.1.1 PRIVATE
10.3.1.2 PUBLIC
10.4 PHYSICIAN OFFICES
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.6 RESEARCH INSTITUTES
10.7 OTHERS
11 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.3.1 ONLINE
11.3.2 OFFLINE
11.4 OTHERS
12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRIES
12.1 EUROPE
12.1.1 GERMANY
12.1.2 U.K.
12.1.3 FRANCE
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 NETHERLANDS
12.1.8 TURKEY
12.1.9 BELGIUM
12.1.10 SWEDEN
12.1.11 POLAND
12.1.12 DENMARK
12.1.13 NORWAY
12.1.14 FINLAND
12.1.15 REST OF EUROPE
13 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENTS
15.2 DIASORIN S.P.A
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 SOULUTION PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 BIOMERIEUX
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS/NEWS
15.4 THERMO FISHER SCIENTIFIC INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENTS
15.5 QIAGEN
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 ABBOTT
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS/NEWS
15.7 BD VERITOR (BD)
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 BIOCARTIS
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BIO-RAD LABORATORIES, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 BOSCH HEALTHCARE SOLUTIONS GMBH
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 DANAHER CORPORATION
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 HOLOGIC, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS/NEWS
15.13 PATHOFINDER
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 QUIDELORTHO CORPORATION
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS/NEWS
15.15 SEEGENE INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 COST OF MULTIPLEX DIAGNOSTIC PRODUCT IN USD
TABLE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 3 EUROPE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 4 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 6 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 7 EUROPE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 10 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 11 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 13 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 14 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 16 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 17 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 18 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 19 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 EUROPE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 22 EUROPE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 25 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 26 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 27 EUROPE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 29 EUROPE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 31 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 GERMANY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 34 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 35 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 36 GERMANY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 37 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 38 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 39 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 40 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 42 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 43 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 45 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 46 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 48 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 49 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 50 GERMANY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 GERMANY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 52 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 53 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 54 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 55 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 56 GERMANY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 58 GERMANY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 59 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 60 U.K. ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 63 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 64 U.K. MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 67 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 68 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 69 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 70 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 71 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 73 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 74 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 76 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 77 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 U.K. VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 U.K. BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 81 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 82 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 83 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 84 U.K. CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 86 U.K. RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 87 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 FRANCE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 91 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 92 FRANCE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 94 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 95 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 96 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 98 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 99 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 101 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 102 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 104 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 105 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 FRANCE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 FRANCE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 109 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 110 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 112 FRANCE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 113 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 114 FRANCE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 115 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 ITALY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 119 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 120 ITALY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 122 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 123 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 124 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 126 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 127 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 129 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 130 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 132 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 133 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 ITALY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 ITALY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 137 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 138 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 139 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 140 ITALY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 142 ITALY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 143 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 SPAIN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 145 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 146 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 147 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 148 SPAIN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 149 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 151 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 152 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 154 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 155 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 156 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 157 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 158 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 159 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 160 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 161 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 162 SPAIN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 SPAIN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 165 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 166 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 168 SPAIN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 170 SPAIN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 171 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 172 RUSSIA ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 173 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 175 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 176 RUSSIA MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 179 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 180 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 181 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 182 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 183 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 185 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 186 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 187 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 188 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 189 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 RUSSIA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 191 RUSSIA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 192 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 193 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 194 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 196 RUSSIA CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 198 RUSSIA RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 200 NETHERLANDS ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 201 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 203 NETHERLANDS MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 204 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 206 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 207 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 209 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 210 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 211 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 212 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 214 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 215 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 NETHERLANDS VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 NETHERLANDS BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 219 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 220 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 222 NETHERLANDS CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 224 NETHERLANDS RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 SWITZERLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 228 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 229 SWITZERLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 230 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 231 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 232 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 233 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 235 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 236 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 237 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 238 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 239 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 241 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 242 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 243 SWITZERLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 244 SWITZERLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 245 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 246 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 247 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 249 SWITZERLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 251 SWITZERLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 253 TURKEY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 254 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 256 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 257 TURKEY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 258 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 259 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 260 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 261 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 262 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 263 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 264 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 266 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 267 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 269 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 270 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 TURKEY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 TURKEY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 274 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 275 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 276 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 277 TURKEY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 278 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 279 TURKEY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 280 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 281 BELGIUM ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 282 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 284 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 285 BELGIUM MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 286 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 288 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 289 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 290 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 291 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 292 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 293 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 294 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 295 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 296 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 297 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 298 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 BELGIUM VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 BELGIUM BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 301 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 302 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 303 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 305 BELGIUM CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 307 BELGIUM RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 309 SWEDEN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 312 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 313 SWEDEN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 315 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 316 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 317 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 319 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 320 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 322 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 323 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 325 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 326 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 SWEDEN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 SWEDEN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 329 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 330 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 331 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 332 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 333 SWEDEN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 334 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 335 SWEDEN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 336 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 POLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 338 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 339 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 340 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 341 POLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 342 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 344 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 345 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 346 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 347 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 348 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 349 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 350 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 351 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 352 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 353 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 354 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 355 POLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 POLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 358 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 359 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 361 POLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 363 POLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 365 DENMARK ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 366 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 367 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 368 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 369 DENMARK MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 371 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 372 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 373 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 374 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 375 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 376 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 377 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 378 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 379 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 380 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 381 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 382 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 383 DENMARK VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 384 DENMARK BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 385 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 386 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 387 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 388 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 389 DENMARK CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 390 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 391 DENMARK RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 392 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 NORWAY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 394 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 396 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 397 NORWAY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 398 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 400 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 401 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 402 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 403 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 404 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 405 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 406 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 407 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 409 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 410 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 411 NORWAY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 412 NORWAY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 413 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 414 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 415 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 417 NORWAY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 419 NORWAY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 420 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 421 FINLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 423 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 424 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 425 FINLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 426 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 427 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 428 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 429 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 430 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 431 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 432 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 433 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 434 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 435 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 436 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 437 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 438 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 439 FINLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 FINLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 441 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 442 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 443 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 444 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 445 FINLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 446 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 447 FINLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 448 REST OF EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
图片列表
FIGURE 1 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
FIGURE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DROC ANALYSIS
FIGURE 4 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COUNTRY-WISE MARKET ANALYSIS
FIGURE 5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS.
FIGURE 7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
FIGURE 11 THREE SEGMENTS COMPRISE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE (2024)
FIGURE 12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 RISING PREVALENCE OF INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 ACCESSORIES & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 16 DROC ANALYSIS
FIGURE 17 TOTAL NUMBER OF CASES OF TUBERCULOSIS IN 2022 AND 2023
FIGURE 18 TOTAL NUMBER OF CASES OF SEXUALLY TRANSMITTED INFECTIONS (STIS)
FIGURE 19 INCREASE IN THE SHARE OF THE POPULATION AGED 65 YEARS AND OVER BETWEEN 2014 AND 2024
FIGURE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2024
FIGURE 21 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 22 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2024
FIGURE 25 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 26 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, CAGR (2025-2032)
FIGURE 27 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, LIFELINE CURVE
FIGURE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2024
FIGURE 29 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2025 TO 2032 (USD THOUSAND)
FIGURE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, CAGR (2025-2032)
FIGURE 31 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, LIFELINE CURVE
FIGURE 32 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2024
FIGURE 33 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 34 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, CAGR (2025-2032)
FIGURE 35 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 37 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 38 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 39 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SNAPSHOT, 2024
FIGURE 41 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY SHARE 2024 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
